Planning Strategies’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24.6K Buy
47
+2
+4% +$1.02K 0.01% 230
2026
Q2
$22.4K Buy
+45
New +$19.9K 0.01% 232

Other funds holding VRTX

Planning Strategies's VRTX Position: Q3 2026 in Review

Planning Strategies increased its Vertex Pharmaceuticals (VRTX) stake by 4.4% in Q3 2026, buying an estimated $1.02K and bringing the position to 47 shares worth $24.6K. The position accounts for 0.01% of the portfolio, ranked #230.

Planning Strategies first reported a position in VRTX in Q2 2026 and has held it in 2 quarters since. 1,653 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Planning Strategies held 47 shares of Vertex Pharmaceuticals worth $24.6K as of Q3 2026.
  • Planning Strategies bought 2 Vertex Pharmaceuticals shares in Q3 2026, an estimated $1.02K.
  • Vertex Pharmaceuticals made up 0.01% of Planning Strategies's portfolio in Q3 2026, its #230 holding.
  • Planning Strategies first reported a position in Vertex Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 1,653 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Planning Strategies's 13F filing for Q3 2026, filed 2 Oct 2026.